Cargando…

Medical Approaches in Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) represents one of the most aggressive endocrine tumors. In spite of a correct therapeutic strategy based on a multidisciplinary approach between endocrinologist, surgeon and oncologist, the prognosis is often poor. Surgery is the mainstay treatment in ACC. Mitotane, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paragliola, Rosa Maria, Corsello, Andrea, Locantore, Pietro, Papi, Giampaolo, Pontecorvi, Alfredo, Corsello, Salvatore Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760807/ https://www.ncbi.nlm.nih.gov/pubmed/33260476 http://dx.doi.org/10.3390/biomedicines8120551

Ejemplares similares

Role of Mitotane in Adrenocortical Carcinoma – Review and State of the art
por: Paragliola, Rosa Maria, et al.
Publicado: (2018)

Cushing’s Syndrome Effects on the Thyroid
por: Paragliola, Rosa Maria, et al.
Publicado: (2021)

Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' Disease
por: Paragliola, Rosa Maria, et al.
Publicado: (2019)

Cortisol circadian rhythm and jet-lag syndrome: evaluation of salivary cortisol rhythm in a group of eastward travelers
por: Paragliola, Rosa Maria, et al.
Publicado: (2021)

Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis
por: Paragliola, Rosa Maria, et al.
Publicado: (2017)

Pediatric Cushing's Disease and Pituitary Incidentaloma: Is This a Real Challenge?
por: Paragliola, Rosa Maria, et al.
Publicado: (2014)

Clinical utility of lanreotide Autogel(®) in gastroenteropancreatic neuroendocrine tumors
por: Paragliola, Rosa Maria, et al.
Publicado: (2016)

Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma
por: Paragliola, Rosa Maria, et al.
Publicado: (2023)

Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients
por: Delle Cese, Francesca, et al.
Publicado: (2021)

Treating Hypopituitarism in the Over 65s: Review of Clinical Studies
por: Paragliola, Rosa Maria, et al.
Publicado: (2023)

46,XY Disorder of Sex Development Caused by 17α-Hydroxylase/17,20-Lyase Deficiency due to Homozygous Mutation of CYP17A1 Gene: Consequences of Late Diagnosis
por: Papi, Giampaolo, et al.
Publicado: (2018)

Clinical Concepts on Thyroid Emergencies
por: Papi, Giampaolo, et al.
Publicado: (2014)

Genetic Basis of ACTH-Secreting Adenomas
por: Locantore, Pietro, et al.
Publicado: (2022)

Medullary Thyroid Carcinoma With Exon 2 p.L56M RET Variant: Clinical Particular Features in Two Patients
por: Paragliola, Rosa M., et al.
Publicado: (2018)

Pregnancy and Prenatal Management of Congenital Adrenal Hyperplasia
por: Cera, Gianluca, et al.
Publicado: (2022)

A novel MEN1 pathogenic variant in an Italian patient with multiple endocrine neoplasia type 1
por: Corsello, Andrea, et al.
Publicado: (2020)

Lenvatinib treatment for thyroid cancer in COVID era: safety in a patient with lung metastases and SARS-CoV-2 infection
por: Locantore, Pietro, et al.
Publicado: (2021)

The Interplay between Immune System and Microbiota in Osteoporosis
por: Locantore, Pietro, et al.
Publicado: (2020)

Parathyroid Gland Involvement by Thyroid Cancer: Results from a Large Series of Thyroidectomies Performed in Two Italian University Hospitals and Review of the Literature
por: Papi, Giampaolo, et al.
Publicado: (2014)

Iodine Supplementation: Usage “with a Grain of Salt”
por: Prete, Alessandro, et al.
Publicado: (2015)

Immune Checkpoint Inhibitors as a Threat to the Hypothalamus–Pituitary Axis: A Completed Puzzle
por: Barnabei, Agnese, et al.
Publicado: (2022)

A rare case of juvenile hypertension: coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism
por: Paragliola, Rosa Maria, et al.
Publicado: (2015)

Parathyroid Carcinoma All-In-One, a Rare Life-Threatening Case With Multiple Systemic Manifestations: Case Report and Review of the Literature
por: Zelano, Lorenzo, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?
por: Barnabei, Agnese, et al.
Publicado: (2022)

Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task
por: Barnabei, Agnese, et al.
Publicado: (2022)

The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications
por: Isidori, Andrea M., et al.
Publicado: (2015)

Editorial: The Unusual Presentation of Thyroid Disorders
por: Papi, Giampaolo, et al.
Publicado: (2019)

Case Report: Papillary thyroid carcinoma in Goltz–Gorlin syndrome
por: Costanza, Flavia, et al.
Publicado: (2023)

Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
por: Fiorentini, Chiara, et al.
Publicado: (2019)

Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)

Macronutrient balance and micronutrient amounts through growth and development
por: Savarino, Giovanni, et al.
Publicado: (2021)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

FMF is not always “fever”: from clinical presentation to “treat to target”
por: Maggio, Maria Cristina, et al.
Publicado: (2020)

Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen
por: Turla, Antonella, et al.
Publicado: (2022)

Apoptosis regulation in adrenocortical carcinoma
por: Pereira, Sofia S, et al.
Publicado: (2019)

Surgical Management of Adrenocortical Carcinoma: Current Highlights
por: Cavallaro, Giuseppe, et al.
Publicado: (2021)

Laparoscopic Adrenalectomy for Large Adrenocortical Carcinoma
por: Machado, Norman Oneil, et al.
Publicado: (2015)

The challenge of developmental therapeutics for adrenocortical carcinoma
por: Costa, Ricardo, et al.
Publicado: (2016)

The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma
por: Karwacka, Izabela, et al.
Publicado: (2021)

Adrenocortical Carcinoma in Childhood: A Systematic Review
por: Riedmeier, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p4j2irnm1ct588h3l9m2474j3h